Quick Answer
iSpecimen Inc. reported Total Revenue of $9.29 million for the year ending 2024.
- iSpecimen Inc. showed a decrease of -6.4% in Total Revenue from 2023 to 2024.
- This data is from iSpecimen Inc.'s annual report (Form 10-K), filed with the SEC on April 14, 2025.
- XBRL data for this metric is available from 2020 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.50 million | Q3 2020: $2.25 million | Q1 2021: $2.96 million | Q2 2021: $2.90 million | Q3 2021: $2.72 million | Q1 2022: $2.52 million | Q2 2022: $2.34 million | Q3 2022: $2.58 million | Q1 2023: $2.95 million | Q2 2023: $1.63 million | Q3 2023: $2.78 million | Q1 2024: $2.29 million | Q1 2024: $2.29 million | Q2 2024: $2.86 million | Q2 2024: $2.86 million | Q3 2024: $2.66 million | Q3 2024: $2.66 million | Q1 2025: $1.06 million | Q2 2025: $713.1 thousand | Q3 2025: $106.6 thousand.
- Over the full 6 years of available data (2020 to 2024), iSpecimen Inc.'s Total Revenue has grown by 13.5%.
- Historical annual values: Fiscal year 2024: $9.29 million | Fiscal year 2023: $9.93 million | Fiscal year 2023: $9.93 million | Fiscal year 2022: $10.40 million | Fiscal year 2021: $11.14 million | Fiscal year 2020: $8.18 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: